Total Payments
$1,136
2024 Payments
$212.17
Companies
13
Transactions
74
Payment Breakdown by Category
Food & Beverage$1,136 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,136 | 74 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $312.65 | 23 | $0 (2022) |
| Lilly USA, LLC | $296.81 | 17 | $0 (2024) |
| ABBVIE INC. | $152.62 | 10 | $0 (2024) |
| Amarin Pharma Inc. | $115.94 | 8 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $71.08 | 5 | $0 (2018) |
| Axsome Therapeutics, Inc. | $41.39 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $36.74 | 2 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $30.09 | 2 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $24.06 | 1 | $0 (2024) |
| Allergan, Inc. | $19.10 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $212.17 | 11 | Lilly USA, LLC ($95.48) |
| 2023 | $124.75 | 7 | Lilly USA, LLC ($80.96) |
| 2022 | $58.54 | 4 | Lilly USA, LLC ($28.75) |
| 2021 | $235.96 | 16 | Novo Nordisk Inc ($111.82) |
| 2020 | $186.90 | 13 | Novo Nordisk Inc ($67.46) |
| 2019 | $112.93 | 8 | Amarin Pharma Inc. ($45.40) |
| 2018 | $102.92 | 8 | Merck Sharp & Dohme Corporation ($41.48) |
| 2017 | $101.63 | 7 | Novo Nordisk Inc ($54.95) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: UROLOGY | ||||||
| 07/16/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Diabetes | ||||||
| 06/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/23/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: IMMUNOLOGY | ||||||
| 03/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: Diabetes | ||||||
| 03/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Diabetes | ||||||
| 10/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Diabetes | ||||||
| 04/13/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 01/17/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Diabetes | ||||||
| 08/30/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, MOUNJARO | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Diabetes | ||||||
| 05/13/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Diabetes | ||||||
| 10/07/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Diabetes | ||||||
| 08/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/21/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Diabetes | ||||||
About Dr. Jeffrey Harris, M.D
Dr. Jeffrey Harris, M.D is a Infectious Disease healthcare provider based in Newport News, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225098213.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Harris, M.D has received a total of $1,136 in payments from pharmaceutical and medical device companies, with $212.17 received in 2024. These payments were reported across 74 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,136).
Ad
Practice Information
- Specialty Infectious Disease
- Location Newport News, VA
- Active Since 03/24/2006
- Last Updated 05/03/2017
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1225098213
Products in Payments
- Ozempic (Drug) $204.76
- TRULICITY (Drug) $142.13
- Vascepa (Drug) $115.94
- MOUNJARO (Drug) $100.56
- UBRELVY (Drug) $90.78
- Victoza (Drug) $79.41
- VRAYLAR (Drug) $63.90
- JANUVIA (Drug) $58.60
- Auvelity (Drug) $41.39
- JARDIANCE (Drug) $39.56
- LONHALA MAGNAIR (Drug) $30.09
- GEMTESA (Drug) $24.06
- INJECTAFER (Drug) $19.66
- Movantik (Drug) $17.08
- SYNTHROID (Drug) $17.04
- Rybelsus (Drug) $14.86
- EMGALITY (Drug) $14.56
- RYBELSUS (Drug) $13.62
- PREVNAR - 13 (Biological) $12.50
- ZOSTAVAX (Biological) $12.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Newport News
Andrea Gonzalez, M.d, M.D
Infectious Disease — Payments: $19,320
Infectious Disease $19,320
Dr. Martha Mooney, Md, MD
Infectious Disease — Payments: $768.23
Infectious Disease $768.23
Rohit Kalia, Md, MD
Infectious Disease — Payments: $301.86
Infectious Disease $301.86
Dr. Prakash Kafle, M.d, M.D
Infectious Disease — Payments: $274.09
Infectious Disease $274.09
Dr. Sharon Hopson, M.d, M.D
Infectious Disease — Payments: $108.19
Infectious Disease $108.19